PET In The Diagnosis Of Head And Neck Cancer
Published 2020 · Medicine
Download PDFAnalyze on Scholarcy
In current clinical practice, the standard approach for initial assessment of head and neck cancer (HNC) is clinical examination followed by neck ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). Compared with these modalities, fluorodeoxyglucose (FDG)-positron emission tomography (PET) may provide unique information about metabolic characteristics. The abnormal elevation of FDG uptake has been shown to be specifically induced in tumor cells because of its low rate of dephosphorylation. Based on this theory, FDG-PET can be used to detect malignant lesions, differentiate benign from malignant lymph nodes (LNs), detect the primary site of unknown primary tumors, plan radiation therapy, and detect tumor recurrence after treatment. In addition, whole-body PET acquisition can be utilized to provide information about the existence of concurrent or distant carcinoma. Another advantage of PET is the capability of robust semi-quantification of metabolic changes by calculating standardized uptake values (SUV). This information can be used to predict prognosis or assess response to therapy. This chapter aims to highlight the use, benefits, and limitations of PET in HNC.
This paper references
FDG-PET/CT for discrimination between malignant necrotic lymph nodes and benign cystic lesions in the neck
Peymaneh Mobarak-Abadi (2015)
Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Shao Hui Huang (2013)
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis
Kyoungjune Pak (2014)
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.
Joël Castelli (2016)
Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases.
Stephan K. Haerle (2011)
Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.
Roland Martens (2019)
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.
Shao Hui Huang (2013)
The unknown biology of the unknown primary tumour: a literature review.
Agnès J. van de Wouw (2003)
Volumetric 18F‐FDG‐PET parameters as predictors of locoregional failure in low‐risk HPV‐related oropharyngeal cancer after definitive chemoradiation therapy
Thong Chotchutipan (2019)
Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?
Ronan Abgral (2009)
Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.
Haïtham Mirghani (2015)
Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma
Esther Mena (2017)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.
Jeffrey C Weinreb (2016)
FDG PET/MR for lymph node staging in head and neck cancer.
I. Platzek (2014)
Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
Songji Zhao (2005)
Using FDG-PET to Measure Early Treatment Response in Head and Neck Squamous Cell Carcinoma: Quantifying Intrinsic Variability in Order to Understand Treatment-Induced Change
Jenny K Hoang (2013)
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck ca
Hisham Mehanna (2017)
Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer.
Benjamin R Roman (2015)
Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.
Val J. Lowe (2019)
Chewing gum causing a very high FDG uptake of the tongue on PET scan.
Satheesh K. Kathula (2007)
Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer.
Chadwick L Wright (2019)
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Maura L. Gillison (2008)
Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
Jae Ryung Lee (2015)
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas
Edmund A Mroz (2015)
Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
Sara Sheikhbahaei (2015)
Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET
Florent Tixier (2012)
Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
Jenny K Hoang (2014)
Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence.
Allen S Ho (2013)
Chest radiography or chest CT plus head and neck CT versus 18F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer.
Y R Kim (2019)
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy
Nils Helsen (2017)
Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer
Nai-Ming Cheng (2014)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl (2009)
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Michael D Cabana (1999)
Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Shao Hui Huang (2012)
Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
Osama R. Mawlawi (2006)
18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort
Mathieu Hatt (2015)
The Effect of Small Tumor Volumes on Studies of Intratumoral Heterogeneity of Tracer Uptake
Frank J. Brooks (2014)
Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
Pouya Ziai (2016)
Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Reema Goel (2017)
Characterization of PET/CT images using texture analysis: the past, the present… any future?
Mathieu Hatt (2016)
Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner
Gaspar Delso (2011)
Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI.
Michael M. Lell (2000)
PET/CT Imaging and Human Papilloma Virus–Positive Oropharyngeal Squamous Cell Cancer: Evolving Clinical Imaging Paradigm
Rathan Subramaniam (2014)
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance
Nils Helsen (2018)
Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
Hye Ran Hong (2014)
Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: are we changing life expectancy?
Matthew E Spector (2012)
Tumor Volume Assessment by 18F-FDG PET/CT in Patients with Oral Cavity Cancer with Dental Artifacts on CT or MR Images
C H Baek (2008)
Screening for distant metastases in patients with head and neck cancer.
Remco de Bree (2000)
Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.
Joo Hyun O (2016)
Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
Yuka Yamamoto (2007)
PET/MR Outperforms PET/CT in Suspected Occult Tumors
Tetsuro Sekine (2017)
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.
B O'Sullivan (2012)
Tumor Metabolic Features Identified by 18F-FDG PET Correlate with Gene Networks of Immune Cell Microenvironment in Head and Neck Cancer
Kwon Joong Na (2018)
Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy.
Roy A Raad (2016)
Intratherapy or Posttherapy FDG PET or FDG PET/CT for Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis of Prognostic Studies.
Sara Sheikhbahaei (2015)
Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck—a meta-analysis comparing different imaging modalities
Li-Jen Liao (2011)
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences
Minerva Becker (2017)
Forty years experience of treating cancer of unknown primary
Nicholas Pavlidis (2007)
Practical approach to diagnostic CT combined with PET.
Terence Z. Wong (2007)
Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon.
David Goldenberg (2008)
Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma
Nai-Ming Cheng (2013)
Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma
Myo Min (2015)
Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck
Sungheon Kim (2009)
Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer
Matias Riihimäki (2012)
Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma
B Zhang (2010)
Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer.
Rakesh Kumar (2016)
Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Young-Hoon Joo (2014)
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Jon M Moan (2019)
Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma
D A Krieger (2017)
Biologic Imaging of Head and Neck Cancer: The Present and the Future
A Srinivasan (2012)
High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.
Edmund A Mroz (2013)
HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma
Caroline C Xu (2013)
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
Sugama Chicklore (2012)
Contrast-Enhanced PET/MR Imaging Versus Contrast-Enhanced PET/CT in Head and Neck Cancer: How Much MR Information Is Needed?
Felix Kuhn (2014)
Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study.
Ayse Tuba Karagulle Kendi (2017)
Interobserver and intermodality variability in GTV delineation on simulation CT, FDG-PET, and MR Images of Head and Neck Cancer.
Carryn Anderson (2014)
(18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis.
Guo-Zeng Xu (2011)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell (2013)
PET Changes Management and Improves Prognostic Stratification in Patients with Head and Neck Cancer: Results of a Multicenter Prospective Study
Andrew M. Scott (2008)
Human papillomavirus and survival of patients with oropharyngeal cancer.
K Kian Ang (2010)
Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis
Axel Sahovaler (2019)
The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Christopher S. Hollenbeak (2001)
[Distant metastasis of squamous epithelial carcinomas of the upper aerodigestive tract. The effect of clinical tumor parameters and course of illness].
Martin C. Jäckel (1999)
Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Mathieu Leclerc (2015)
The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
Kee H. Wong (2016)
An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts.
O R Merino (1977)
Clinical Significance of Incidental 18F-FDG Uptake in the Pyriform Sinus Detected by PET/CT
Young Seok Cho (2016)
Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation
Marcelo Araujo Queiroz (2014)
Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up
Shu-Hang Ng (2008)
EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
Nicolas Aide (2017)
Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
Verena Ruhlmann (2016)
Fernmetastasierung von Plattenepithelkarzinomen des oberen Aerodigestivtrakts Der Einfluß klinischer Tumorparameter und des Krankheitsverlaufs
Martin C. Jäckel (1999)
A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.
M G Isles (2008)
Head and neck cancers: Clinical practice guidelines in oncology
David G. Pfister (2011)
Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?
Hyung-Jun Im (2017)
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.
Uwe Haberkorn (1991)
Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity.
Yasser G Abd El-Hafez (2011)
Do 18F-FDG PET/CT Parameters in Oropharyngeal and Oral Cavity Squamous Cell Carcinomas Indicate HPV Status?
Ayse Tuba Karagulle Kendi (2015)
Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach.
Jenny K Hoang (2013)
18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck
Peymaneh Abadi (2016)
18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis
Peng Xie (2010)
The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus–Positive Versus Human Papillomavirus–Negative Patients With Oropharyngeal Cancer
Zeno A. R. Gouw (2019)
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
John M Floberg (2018)
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer
Renaud Ciappuccini (2016)
18F‐FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta‐analysis of reported studies
Erin T Wong (2019)
Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies.
Yuji Nakamoto (2003)
Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell Cancer
Maureen McDermott (2013)
18F-FDG PET and PET/CT Patient Preparation: A Review of the Literature*
Devaki Shilpa Sudha Surasi (2014)
Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer
Max Rohde (2017)
Interim 18F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review.
Cristina Garibaldi (2017)
Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis
Thomas Christian Kwee (2008)
Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT
Tetsuro Sekine (2017)
FDG PET/CT Imaging of Oropharyngeal Squamous Cell Carcinoma: Characteristics of Human Papillomavirus–Positive and –Negative Tumors
Abdel Kader Tahari (2014)
Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.
Florian Dammann (2005)
Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.
Ling Yuen Wong (2003)
Accuracy of Response Assessment Positron Emission Tomography-Computed Tomography Following Definitive Radiotherapy Without Chemotherapy for Head and Neck Squamous Cell Carcinoma.
Moses Arunsingh (2019)
Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor.
C. René Leemans (1994)
Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer
Ivayla Apostolova (2014)
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Max Lonneux (2010)
Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder.
Sue S. Yom (2015)
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger (2012)
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Panayiotis A. Kyzas (2008)
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.
Dominique Delbeke (2006)
Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
Todd M. Blodgett (2005)
Comparison of Whole-Body PET/CT, Dedicated High-Resolution Head and Neck PET/CT, and Contrast-Enhanced CT in Preoperative Staging of Clinically M0 Squamous Cell Carcinoma of the Head and Neck
Rosana Souza Rodrigues (2009)
A systematic review of the factors affecting accuracy of SUV measurements.
Michael C. C. Adams (2010)
Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation
Musaddiq J Awan (2016)
NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer
Sue Sun Yom (2019)
Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring.
Daniel M Beswick (2012)
PET/CT for assessing mandibular invasion by intraoral squamous cell carcinomas.
Elizabeth Babin (2008)
FDG-PET staging and importance of lymph node SUV in head and neck cancer
Gregory J Kubicek (2010)
PET/MRI and PET/CT in follow-up of head and neck cancer patients
Marcelo Araujo Queiroz (2014)
PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system.
Tetsuro Sekine (2017)
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT
Yuko Suenaga (2015)
Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
Pattana Wangaryattawanich (2018)
The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma.
María Luisa García Martel (2017)
Prognostic value of 18F-FDG PET/CT functional parameters in patients with head and neck cancer: a meta-analysis
Lihong Wang (2019)
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET
Tove J Grönroos (2014)
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
Sho Koyasu (2014)
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.
Vasavi Paidpally (2012)
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects.
Robert P. Takes (2012)
The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language?
Daniel Vanel (2007)
Prognostic value of simultaneous 18F-FDG PET/MRI using a combination of metabolo-volumetric parameters and apparent diffusion coefficient in treated head and neck cancer
Yong-Il Kim (2018)
Role of 2-Fluoro-2-Deoxyglucose PET/Computed Tomography in Carcinoma of Unknown Primary.
Alok Suresh Pawaskar (2015)
Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma.
Richard L. Wahl (1992)
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma.
Byung-Joon Chun (2016)
Visual Versus Quantitative Assessment of Intratumor 18F-FDG PET Uptake Heterogeneity: Prognostic Value in Non–Small Cell Lung Cancer
Florent Tixier (2014)
18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients
Claudio Spick (2016)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard (2014)
FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Christiaan A. Krabbe (2009)
Carcinoma of unknown primary: focused evaluation.
Gauri R. Varadhachary (2011)
A Comparative Study of Fused FDG PET/MRI, PET/CT, MRI, and CT Imaging for Assessing Surrounding Tissue Invasion of Advanced Buccal Squamous Cell Carcinoma
Shu-Hua Huang (2011)
LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.
Donald G. Mitchell (2015)
PET/MR in cancers of the head and neck.
Marcelo Araujo Queiroz (2015)
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Hisham Mehanna (2016)
FDG PET/CT in carcinoma of unknown primary
Thomas Christian Kwee (2009)
PET-based prognostic survival model after radiotherapy for head and neck cancer
Joël Castelli (2018)
Reduction of 18F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier Detectors.
Tetsuro Sekine (2018)
Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer
Johanna Sjövall (2015)
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Johnny Kao (2009)
Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer
Seng Chuan Ong (2008)
18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis.
Lihong Zhu (2013)
"Puffed-cheek" CT improves evaluation of the oral cavity.
Jane L. Weissman (2001)
Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Howard Yu-Hao Liu (2019)
Implementation of a Novel Surveillance Template for Head and Neck Cancer: Neck Imaging Reporting and Data System (NI-RADS).
A H Aiken (2016)
Feasibility and Incremental Benefit of Puffed-Cheek 18F-FDG PET/CT on Oral Cancer Patients
Chih-Yung Chang (2013)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Carole Fakhry (2008)
Osteoradionecrosis after Radiation Therapy for Head and Neck Cancer: Differentiation from Recurrent Disease with CT and PET/CT Imaging
L M Alhilali (2014)
PET imaging biomarkers in head and neck cancer
Sarah Differding (2014)
Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality
Ida Sonni (2018)
Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma.
Luiz Paulo Kowalski (2005)
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes
Charles Marcus (2014)
PET/MRI and PET/CT: is there room for both at the top of the food chain?
Torsten Kuwert (2015)
Predicting extracapsular spread of head and neck cancers using different imaging techniques: a systematic review and meta-analysis.
Zhifei Su (2016)
Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Christian Cohade (2003)
18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Shuichao Gao (2014)
Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma
Jacob Høygaard Rasmussen (2017)
Impact of Concurrent Diagnostic Level CT With PET/CT on the Utilization of Stand-Alone CT and MRI in the Management of Head and Neck Cancer Patients
Rathan Subramaniam (2013)
Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
Christoph Alexander Karlo (2014)
Extracapsular spread in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Maxime Mermod (2016)
Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck
Snehal G. Patel (2016)
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
Tejpal Gupta (2011)